Focused lab researchers wearing goggles conducting chemical experiments

Sep 27, 2023 | By Val Brickates Kennedy / Seeking Alpha

Quanterix (NASDAQ:QTRX) said that it has launched a biomarker blood test called LucentAD to help diagnose patients experiencing symptoms consistent with early Alzheimer’s disease, or AD.

The diagnostics company said the test allows healthcare professionals to quickly assess the patient for the likelihood of amyloid pathologies associated with AD. The test will be processed by the company’s CLIA labs through its new Lucent Diagnostics portal for healthcare professionals. …

Read the Full Article

Banner CTA

LET’S TALK

Subscribe to get the latest insights in your inbox

Delivering diagnostic advancements, powered by research and technology excellence

Success check

Disclaimer

The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.